In recent years, messenger RNA (mRNA) vaccines have shown significant success in preventing viral and bacterial infections, ...

Every winter, Austin gets walloped by cedar fever: runny noses, scratchy throats, watering eyes, and canceled plans as ...

Many people first learned about mRNA vaccines during the coronavirus pandemic, when the companies Pfizer-BioNTech and Moderna released their COVID-19 vaccines. The Pfizer-BioNTech shot was the first ...

Accelerated by the COVID-19 pandemic, research is now exploring vaccines capable not only of preventing infections, but also ...

Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine ...

Frankfurt: German agrichemical giant Bayer confirmed to AFP on Wednesday that it was suing American pharmaceutical firms Pfizer, Moderna and Johnson and Johnson ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

With the US poised to lose its measles-free status, an expert from GeoVax discusses how to win back the minds of Americans.

Set for multiple late-stage readouts in oncology in 2026, BioNTech is entering a crucial phase of its roadmap beyond Covid-19 ...

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).